AI-DRIVEN MICROBIOME-BASED BIOMARKERS FOR EARLY DIAGNOSIS OF CANCER AND AUTOIMMUNE DISEASES: CURRENT ADVANCES AND FUTURE PERSPECTIVES. rjnmsr [Internet]. 2026 Jul. 16 [cited 2026 Sep. 23];4(3):822-3. Available from: https://nmsreview.org/index.php/rjnmsr/article/view/1096